decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / ETHYLENEDIAMINE-TETRA-ACETIC_(EDTA)_CHELATION_THERAPY_FOR_TREATMENT_OF_ATHEROSCLEROSIS
Subscribe or sign in to view the full article.
Article Overview
This article covers a National Coverage Determinations Manual appendix entry addressing the coverage status of EDTA chelation therapy when used for atherosclerosis and related generalized conditions. It is relevant to coders, billers, auditors, and compliance staff who need to understand Medicare coverage policy and related manual guidance. The article presents a policy statement and references a related manual section for additional context.
Why This Topic Matters
Coverage policy affects whether services may be reimbursable and helps compliance teams recognize when a therapy is considered noncovered under the manual.
What You Will Learn
- The general Medicare coverage posture for EDTA chelation therapy in this context.
- How the manual frames this therapy within broader coverage guidance.
- Where to look in the manual for related explanatory context.
- The policy’s relevance to coverage and compliance review.
Who Should Read This
- Medical coders
- Billing specialists
- Compliance staff
- Auditors
- Revenue cycle professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com